No Detail Found!

Assessment of CA 15-3, (cancer antigen CA 15-3) in patients with breast carcinoma.

Author(s)
Javed Altaf Baig Department of Biochemistry, Liaquat National Medical College, Karachi, Pakistan
Junaid Mahmood Alam Department of Biochemistry, Laboratory Services, Liaquat National Hospital, Karachi, Pakistan
Ishrat Sultana Department of Biochemistry, Laboratory Services, Liaquat National Hospital, Karachi, Pakistan
Rabia Shaheen Department of Biochemistry, Laboratory Services, Liaquat National Hospital, Karachi, Pakistan
Sarah Sughra Asghar Department of Biochemistry, Laboratory Services, Liaquat National Hospital, Karachi, Pakistan
Riaz Mahmood Department of Pathology, Govt. Lyari General Hospital, Karachi, Pakistan
Mohammed Baig Dow University of Health Sciences, Karachi, Pakistan
Abstract
The main clinical application of CA 15-3 Cancer antigen suggested to being in monitoring the response to treatment and gives reliable information on the recurrence of disease. In breast carcinoma, carbohydrate antigen 15-3 (CA 15-3), a Mucin component, is the most important and commonly used tumor marker. Several studies suggested that its evaluation could provide valuable clinical information. In this regard, the aim of present study is to assess CA 15-3 in patients with breast carcinoma and its usefulness in monitoring and therapy. Serum samples of female patients (n = 91) suspected of or diagnosed with breast carcinoma were analyzed for CA 15-3 using Electro-chemi-luminescence techniques on Elecsys 1010 and 2010 (Roche Diagnostics, Basel). Significantly elevated levels of CA 15-3 were noted in most of the patients and correlated with their malignant tumor status and clinical conditions. Moreover, breast carcinoma patients showed decrease in CA 15-3 levels post-operatively (although most of them still above normal reference range), depicting successfulness of treatment and intervention, in addition to suggesting that CA 15-3 concentrations can also provide prognostic information. Furthermore, serial concentrations analyses have the potential both to detect recurrences pre-clinically and to monitor the treatment of metastases breast carcinoma. It is concluded that CA 15-3 is currently the most widely used circulating cancer marker for breast carcinoma. CA 15-3 can provide useful information regarding successfulness when comparing pre-operative and post-operative values.
Publication Details
Page(s) 141-146
DOI DOI not available
Published Journal: Pakistan Journal of Biochemistry and Molecular Biology , Volume: 42, Issue: 4, Year: 2009

Request the full text from PASTIC

0

Citations

0

Downloads

100

Views